185 related articles for article (PubMed ID: 19818350)
21. Diagnostic Value of the Hypomethylation of the WISP1 Promoter in Patients with Hepatocellular Carcinoma Associated with Hepatitis B Virus.
Chen LM; Xiang L; Sun WJ; Zhai YJ; Gao S; Fan YC; Wang K
Tohoku J Exp Med; 2020 Dec; 252(4):297-307. PubMed ID: 33239483
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
Kao WY; Yang SH; Liu WJ; Yeh MY; Lin CL; Liu CJ; Huang CJ; Lin SM; Lee SD; Chen PJ; Yu MW
Mol Carcinog; 2017 Feb; 56(2):425-435. PubMed ID: 27254796
[TBL] [Abstract][Full Text] [Related]
23. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.
Nishida N; Nagasaka T; Nishimura T; Ikai I; Boland CR; Goel A
Hepatology; 2008 Mar; 47(3):908-18. PubMed ID: 18161048
[TBL] [Abstract][Full Text] [Related]
24. Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma.
Hu N; Fan XP; Fan YC; Chen LY; Qiao CY; Han LY; Wang K
Tohoku J Exp Med; 2017 Jun; 242(2):93-100. PubMed ID: 28592717
[TBL] [Abstract][Full Text] [Related]
25. Comparison of genome-scale DNA methylation profiles in hepatocellular carcinoma by viral status.
Song MA; Kwee SA; Tiirikainen M; Hernandez BY; Okimoto G; Tsai NC; Wong LL; Yu H
Epigenetics; 2016 Jun; 11(6):464-74. PubMed ID: 27248055
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
[TBL] [Abstract][Full Text] [Related]
27. Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.
Zondervan PE; Wink J; Alers JC; IJzermans JN; Schalm SW; de Man RA; van Dekken H
J Pathol; 2000 Oct; 192(2):207-15. PubMed ID: 11004697
[TBL] [Abstract][Full Text] [Related]
28. Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA.
Zhang YJ; Wu HC; Shen J; Ahsan H; Tsai WY; Yang HI; Wang LY; Chen SY; Chen CJ; Santella RM
Clin Cancer Res; 2007 Apr; 13(8):2378-84. PubMed ID: 17438096
[TBL] [Abstract][Full Text] [Related]
29. Aberrant DNA methylation distinguishes hepatocellular carcinoma associated with HBV and HCV infection and alcohol intake.
Lambert MP; Paliwal A; Vaissière T; Chemin I; Zoulim F; Tommasino M; Hainaut P; Sylla B; Scoazec JY; Tost J; Herceg Z
J Hepatol; 2011 Apr; 54(4):705-15. PubMed ID: 21146512
[TBL] [Abstract][Full Text] [Related]
30. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
31. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis.
Um TH; Kim H; Oh BK; Kim MS; Kim KS; Jung G; Park YN
J Hepatol; 2011 May; 54(5):939-47. PubMed ID: 21145824
[TBL] [Abstract][Full Text] [Related]
32. Differential Serum Cytokine Profiles in Patients with Chronic Hepatitis B, C, and Hepatocellular Carcinoma.
Estevez J; Chen VL; Podlaha O; Li B; Le A; Vutien P; Chang ET; Rosenberg-Hasson Y; Jiang Z; Pflanz S; Ge D; Gaggar A; Nguyen MH
Sci Rep; 2017 Sep; 7(1):11867. PubMed ID: 28928388
[TBL] [Abstract][Full Text] [Related]
33. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).
Lv X; Ye G; Zhang X; Huang T
Medicine (Baltimore); 2017 Sep; 96(38):e8106. PubMed ID: 28930859
[TBL] [Abstract][Full Text] [Related]
34. Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus.
Gulnaz A; Sayyed AH; Amin F; Khan Au; Aslam MA; Shaikh RS; Ali M
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):166-79. PubMed ID: 23044807
[TBL] [Abstract][Full Text] [Related]
35. Methylation of tumor associated genes in tissue and plasma samples from liver disease patients.
Chang H; Yi B; Li L; Zhang HY; Sun F; Dong SQ; Cao Y
Exp Mol Pathol; 2008 Oct; 85(2):96-100. PubMed ID: 18691570
[TBL] [Abstract][Full Text] [Related]
36. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection.
Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H
Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595
[TBL] [Abstract][Full Text] [Related]
37. [Chronic hepatitis B virus infection and the methylation status of p16INK4A promoter].
Zhu R; Li BZ; Ling YQ; Zhang HP; Li H; Liu Y; Hu XQ; Zhu HG
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):166-70. PubMed ID: 17649629
[TBL] [Abstract][Full Text] [Related]
38. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Relationship between Occurrence of Liver Cancer and Methylation of Fragile Histidine Triad (FHIT) and P16 Genes.
Bai Y; Shen Y; Yuan Q; Lv C; Xing Q
Med Sci Monit; 2019 Feb; 25():1301-1306. PubMed ID: 30773529
[TBL] [Abstract][Full Text] [Related]
40. Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma.
Yu MW; Cheng SW; Lin MW; Yang SY; Liaw YF; Chang HC; Hsiao TJ; Lin SM; Lee SD; Chen PJ; Liu CJ; Chen CJ
J Natl Cancer Inst; 2000 Dec; 92(24):2023-8. PubMed ID: 11121465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
